Dannex Ayrton Starwin (XGHA:DASPHARMA) Net Margin %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XGHA:DASPHARMA Dannex Ayrton Starwin PLC XGHA:DASPHARMA
4 GF Score
Price GHS0.44
! 1 Warning Sign
View Full Analysis

What is Dannex Ayrton Starwin Net Margin %?

Dannex Ayrton Starwin XGHA:DASPHARMA 4 Net Margin % is 0.00% as of . 20. GuruFocus rates XGHA:DASPHARMA with a GF Score™ of 4/100. The stock has 1 warning sign investors should review. Among 961 Drug Manufacturers companies, Dannex Ayrton Starwin ranks worse than 104058.17% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Dannex Ayrton Starwin's Net Income for the six months ended in . 20 was GHS0.00 Mil. Dannex Ayrton Starwin's Revenue for the six months ended in . 20 was GHS0.00 Mil. Therefore, Dannex Ayrton Starwin's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Dannex Ayrton Starwin's Net Margin % or its related term are showing as below:


XGHA:DASPHARMA's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.47
* Ranked among companies with meaningful Net Margin % only.

Dannex Ayrton Starwin  (XGHA:DASPHARMA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Dannex Ayrton Starwin Net Margin % Related Terms

Dannex Ayrton Starwin Net Margin % Historical Data

* Premium members only.

The historical data trend for Dannex Ayrton Starwin's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dannex Ayrton Starwin Net Margin % Chart

Dannex Ayrton Starwin Annual Data
Trend
Net Margin %

Dannex Ayrton Starwin Semi-Annual Data
Net Margin %

XGHA:DASPHARMA vs : Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dannex Ayrton Starwin's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dannex Ayrton Starwin Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dannex Ayrton Starwin's Net Margin % distribution charts can be found below:

* The bar in red indicates where Dannex Ayrton Starwin's Net Margin % falls into.


XGHA:DASPHARMA
4GF Score
Dannex Ayrton Starwin PLC XGHA:DASPHARMA
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dannex Ayrton Starwin Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Dannex Ayrton Starwin's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Dannex Ayrton Starwin's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on Dannex Ayrton Starwin and its competitors. According to the industry distribution chart, Dannex Ayrton Starwin ranks #999999 out of 961 companies in the Drug Manufacturers industry.
Is Dannex Ayrton Starwin's Net Margin % too high?
Dannex Ayrton Starwin's current Net Margin % is 0.00%. Based on the distribution chart, Dannex Ayrton Starwin ranks #999999 out of 961 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Dannex Ayrton Starwin has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Dannex Ayrton Starwin's Net Margin % compare to ?
According to the Drug Manufacturers industry distribution chart, Dannex Ayrton Starwin ranks #999999 out of 961 companies for Net Margin %. This places Dannex Ayrton Starwin in the lower half of its industry. The industry median Net Margin % is 5.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.47, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Dannex Ayrton Starwin and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dannex Ayrton Starwin's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dannex Ayrton Starwin stock overvalued right now?
Dannex Ayrton Starwin (XGHA:DASPHARMA) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Dannex Ayrton Starwin's overall GF Score™ is 4/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Dannex Ayrton Starwin (XGHA:DASPHARMA), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dannex Ayrton Starwin Business Description

Comparable Companies
Address No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.
4GF Score

Get the complete analysis for XGHA:DASPHARMA

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

GHS0.44
Price